Sentences with phrase «for epilepsy patients»

UCB, Inc., and Canine Assistants today announced a multi-year partnership to sponsors seizure response dogs for epilepsy patients across the U.S..

If it works for epilepsy patients, it follows that it should be helpful for any person trying to get into ketosis quickly.

Seizure dogs provide an alarm system for epilepsy patients, and diabetic alert dogs are trained to identify the scent changes that accompany hypoglycemia.

With life - changing laser surgery for epilepsy patients, advanced surgical treatments for obesity, and new ways to mobilize the immune system for wellness, we're bringing research to reality and making the extraordinary possible.

The scientists hope that new treatment options will open up for epilepsy patients as a result of their discovery.

«Engineer locates brain's seizure onset zone in record time: Discovery breakthrough for epilepsy patients.»

Not exact matches

Providing patients and physicians with an accurate way to track and report seizures could lead to advancements in how care is provided for those who suffer from conditions, such as epilepsy — 3.4 million people in the US suffer from the condition, according to a CDC estimate.

This article discusses these effects and makes recommendations for gynecologic and obstetric care of patients with epilepsy, with particular focus on pregnancy.

The state's tightly regulated medical marijuana program is due to be in place by January, though state lawmakers who backed the program are pushing for a faster phase in of the program in order to help patients — especially children with epilepsy — now.

The James Lind Alliance have worked with clinicians and patients in this way to identify priorities for research on specific conditions, such as pressure ulcers, alcohol liver related disease, epilepsy and asthma.

In a group of patients who underwent surgery for epilepsy, over half had stem cells where healthy individuals do not have them, according to a study from Sahlgrenska Academy.

Schalk and Leuthardt quickly recruited 12 epilepsy patients as volunteers for their first set of experiments.

So far, researchers with the Allen Institute for Brain Science in Seattle have described the intricate shapes and electrical properties of about 100 nerve cells, or neurons, taken from the brains of 36 patients as they underwent surgery for conditions such as brain tumors or epilepsy.

For the past eight years, he and his colleagues have been studying epilepsy patients who have had electrodes implanted in a region of their brains called the medial temporal lobe, as part of a study to identify the source of their seizures.

In a recent trial of 225 patients, completed in September 2016, participants who took the drug (along with their other epilepsy medications) reduced their nonstop seizures by 42 percent, compared with 17 percent for those taking a placebo.

Guideline authors noted, however, that the evidence for the recommendations is weak, since many of the studies had relatively small numbers of patients with similar types of epilepsy and were conducted at only one institution, so the results may not be generalizable to everyone with epilepsy.

Although surgery has helped some patients such as Shane, uncontrollable epilepsy remains a living nightmare for patients and an intractable foe for clinicians and researchers.

«In the long run, this improved understanding may enable the development of better treatment options for patients suffering from epilepsy.

Given how long it is likely to take for new medications against epilepsy to be tested and approved, some experts argue that more patients with relentless epilepsy could benefit from recent advances in surgical techniques and various methods for stimulating neurons in ways that make them behave less erratically.

According to Devinsky, 10 to 15 percent of patients with otherwise unmanageable epilepsy are potential candidates for the treatment; clinical trials have shown that the implants reduce seizures in the treated group by an average of as much as 66 percent after three to six years of follow - up.

Using a novel combination of technologies, including trio exome sequencing of patient / parental DNA and genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of epilepsy patients with symptoms similar to Dravet syndrome — a severe form of childhood epilepsy that is in many patients resistant to currently available anti-epileptic drugs.

In addition, the creation of a zebrafish model for CHD2 encephalopathy may facilitate the discovery of new drugs that can treat patients with this form of epilepsy.

«In most people the centre for these activities lies in the right half of the brain, in many MS patients however it lies in the left side of the brain, as it does in many epilepsy patients,» says the PhD student and primary author Kathrin Kollndorfer.

In humans, this region could be a target for bringing some brain injury patients out of a comatose state via electrical stimulation, says lead author Nigel Pedersen, MD, assistant professor of neurology at Emory University School of Medicine and an epilepsy specialist at Emory Brain Health Center.

MBANs at Home If all goes well, look for MBANs to fall into three categories in the near future — those used to monitor a patient's general health or «wellness,» those measuring the health of the elderly, and those used to monitor patients with long - term medical conditions such as Parkinson's disease or epilepsy, says Paolo Bonato, director of the Motion Analysis Laboratory at Boston's Spaulding Rehabilitation Hospital and an assistant professor of physical medicine and rehabilitation at Harvard Medical School..

«Neurostimulator for epilepsy seizure control implanted in patients.»

The researchers first analyzed a database of EEG recordings taken from 16 patients who had already undergone surgery for epilepsy.

What's really necessary, Dr. Gaillard says, is real data on efficacy for each of the medications commonly prescribed to pediatric epilepsy patients — a marked vacuum in research that prevents doctors from using evidence - based reasoning when making medication choices.

NYU Langone Medical Center last month became the first hospital outside of a clinical trial site to implant a pacemaker - like device in the brain that may be a game - changer for patients with epilepsy.

Participants were randomized into four different interventions that would analyze how effectively an acupuncture technique known as electroacupuncture — in which embedded needles deliver weak electrical currents — reduces incidents of hot flashes as compared to the epilepsy drug gabapentin, which was previously shown to be effective in reducing hot flashes for these patients.

«Nearly 70 percent of cannabidiol extracts sold online are mislabeled, study shows: Mislabeling may lead to adverse effects for patients, including children with epilepsy.»

However, as early as 2002, Olaf Blanke and others induced OBEs by focal electrical stimulation of the brain's right angular gyrus in a patient undergoing treatment for epilepsy (Nature, vol 419, p 269).

«The disposition for epilepsy in patients with the malformation investigated in our study could potentially be explained by a resulting electrical over-excitability of this nerve fiber sheath,» says Haas.

A recent study led by Alice Lam, MD, PhD, also of the MGH Epilepsy Service and lead author of the current study demonstrated a novel tool for detecting hippocampal seizures not detectible by scalp EEGs in patients with epilepsy, Cole adds, and his team is working to refine this tool and apply it to Alzheimer's disease.

Brains of patients with epilepsy may have smaller overall areas and intensity of activation in their alertness networks, which keep brains ready for incoming stimuli.

«Currently, surgical resection is the treatment of choice for some patients with medically refractory epilepsy,» Chiang said.

For several decades, beginning in the 1960s, neuroscientist Roger Sperry of the California Institute of Technology, psychologist Michael S. Gazzaniga of the University of California, Santa Barbara, and their colleagues studied patients who underwent surgery to sever the corpus callosum (the large band of neural fibers connecting the two hemispheres) in an effort to halt intractable epilepsy.

Merkow and colleagues studied 66 patients who were already undergoing intracranial monitoring of their hippocampus for epilepsy.

AES, the American Academy of Neurology and other professional societies had opposed patients substituting antiepileptic generics for people with epilepsy without consent of the physician or patient out of concern that the U.S. Food and Drug Administration (FDA) was allowing room for too much variability across formulations.

The need for effective generics is essential to some patients who need daily medication to treat serious conditions like epilepsy.

Specific genetic factors were found to be the cause of epilepsy in 40 percent of patients evaluated for first presentation with seizures.

In many patients with severe epilepsies, no cause for the seizures can be identified.

Working with Seattle, Washington — area neurosurgeons, the Allen Institute acquired healthy cells from the cortex — the outermost layer of the brain that coordinates perception, memory, thoughts, and consciousness — from patients undergoing surgery for epilepsy or brain tumors.

In total, they identified 429 new mutations and in 12 % of children, these mutations were considered unequivocally causative for the patient's epilepsy.

He's also committed to preserving patients» memories, which can be a major concern for people living with epilepsy.

At UT Southwestern, Dr. Das also examines epilepsy patients» quality of life and how research treatments are being translated into clinical practice for these patients.

As a neurologist and epileptologist, Dr. Das is an expert at using EEG technology to diagnose patients with epilepsy, selecting the correct medications, and providing surgical evaluations for qualifying patients.

* Deep brain stimulation can reduce seizure frequency and improve quality of life for patients with drug - resistant epilepsy.

The levels of epilepsy care are a useful tool for both patients and healthcare providers to evaluate the appropriateness and quality of specialized epilepsy care.

We obtained cortical tissue that was removed during the course of brain surgery to treat patients for vascular malformations of pharmacoresistant epilepsy.